Literature DB >> 31366827

Novel Compound-Target Interactions Prediction for the Herbal Formula Hua-Yu-Qiang-Shen-Tong-Bi-Fang.

Zihao Wang1, Hui-Heng Lin1, Kegang Linghu1, Run-Yue Huang2,3, Guangyao Li1, Huali Zuo1, Hua Yu1, Ging Chan1, Yuanjia Hu1.   

Abstract

Herbal formulae have a long history in clinical medicine in Asia. While the complexity of the formulae leads to the complex compound-target interactions and the resultant multi-target therapeutic effects, it is difficult to elucidate the molecular/therapeutic mechanism of action for the many formulae. For example, the Hua-Yu-Qiang-Shen-Tong-Bi-Fang (TBF), an herbal formula of Chinese medicine, has been used for treating rheumatoid arthritis. However, the target information of a great number of compounds from the TBF formula is missing. In this study, we predicted the targets of the compounds from the TBF formula via network analysis and in silico computing. Initially, the information of the phytochemicals contained in the plants of the herbal formula was collected, and subsequently computed to their corresponding fingerprints for the sake of structural similarity calculation. Then a compound structural similarity network infused with available target information was constructed. Five local similarity indices were used and compared for their performance on predicting the potential new targets of the compounds. Finally, the Preferential Attachment Index was selected for it having an area under curve (AUC) of 0.886, which outperforms the other four algorithms in predicting the compound-target interactions. This method could provide a promising direction for identifying the compound-target interactions of herbal formulae in silico.

Entities:  

Keywords:  Hua-Yu-Qiang-Shen-Tong-Bi-Fang; herbal formula; in-silico target identification; natural product; network link prediction

Mesh:

Substances:

Year:  2019        PMID: 31366827     DOI: 10.1248/cpb.c18-00808

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  1 in total

1.  Triptolide and l-ascorbate palmitate co-loaded micelles for combination therapy of rheumatoid arthritis and side effect attenuation.

Authors:  Man Li; Guoqiang Wang; Yinyin Yan; Mengyuan Jiang; Zhirong Wang; Zhenqiang Zhang; Xiangxiang Wu; Huahui Zeng
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.